Natus introduces autoSCORE, an innovative AI solution capable of a new era of expert-level clinical EEG interpretation

MIDDLETON, Wis., Aug. 7, 2024 /PRNewswire/ — Natus Medical Incorporated has announced the launch of autoSCORE, the first-of-its-kind artificial intelligence model capable of automatic and comprehensive clinical EEG interpretation, providing accuracy on par with medical experts.

“The development of the world’s first AI model capable of reading clinical EEGs at the level of the best experts in the world is a significant accomplishment,” says Harald Aurlien, co-founder of Holberg EEG and a consultant in clinical neurophysiology at Haukeland University Hospital.

The autoSCORE application was developed in Norway by Holberg EEG using a deep-learning model and trained on the world’s largest dataset of more than 30,000 expertly labeled EEG recordings. The development and validation of the model have been carefully designed to avoid typical errors and sources of bias, and the output is focused on aspects key to the interpretation of clinical EEGs [1].

“The development of the world’s first AI model capable of reading clinical EEGs at the level of the best experts in the world is a significant accomplishment,” says Harald Aurlien, co-founder of Holberg EEG and a consultant in clinical neurophysiology at Haukeland University Hospital. “The partnership and distribution agreement with Natus, one of the world’s largest EEG companies, will help bring this innovative solution to customers around the world.”

The 2023 study “Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence,” published in JAMA, revealed autoSCORE consistently performed with accuracy, sensitivity, and specificity near or above 90% [1]. It also showed the autoSCORE application to be on par with leading human experts while outperforming similar AI models on the market.

“The autoSCORE application has the potential to improve clinical outcomes and value of care for the millions suffering from epilepsy,” states Natus Neuro Chief Executive Officer Chris Landon. “This newly launched solution represents the first of what we expect will be a series of innovative AI applications at Natus designed to deliver efficiency and quality improvements across healthcare.”

Visual EEG review is considered the gold standard for determining abnormalities, but it demands clinical resources and years of specialized training. The AI-enabled autoSCORE application is designed to allow neurocare teams to more efficiently and consistently perform EEG data analysis.

Unlike traditional spike and seizure detectors, the autoSCORE application comprehensively assesses EEG data for multiple clinically relevant abnormalities and provides study-level assessments to inform care teams whether an EEG study is normal or abnormal.

The autoSCORE application has received U.S. Food and Drug Administration clearance for use with routine EEG studies and is currently available in the United States, exclusively with Natus NeuroWorks EEG Software Version 10.

ABOUT NATUS

Natus is trusted by healthcare providers around the globe as the solution source to screen, diagnose, and treat disorders affecting the brain, neural pathways, and sensory nervous systems. The best-in-class Natus solutions, including service, field support and education, enable clinicians to advance their standard of care, improving patient outcomes and quality of life.

ABOUT HOLBERG EEG

Holberg EEG is a spin-off company from the Haukeland University Hospital in Bergen, Norway. Its mission is to unite structured data to be used for new innovations to improve patient care. The company’s current focus is EEG and to gain new knowledge and understanding of the complex brain using artificial intelligence on a huge database of structured labeled EEGs.

  1. Tveit, J., et al., Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence. JAMA Neurology, 2023.

CONTACT:  
Lisa Schuler
Sr. Director, Corporate Communications
Phone: +1 612 528-1332
Email: lisa.schuler@natus.com
www.natus.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/natus-introduces-autoscore-an-innovative-ai-solution-capable-of-a-new-era-of-expert-level-clinical-eeg-interpretation-302216696.html

SOURCE Natus Medical Incorporated

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

3 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

17 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

18 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

18 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

19 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

21 hours ago